510(k) device
Ancora-SB
Aspero Medical, Inc. · Enteroscope And Accessories (FDA, Class II) · First FDA decision Aug 31, 2023, newest May 1, 2026Gastrointestinal bleeding
Last checked: Nov 19, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
2
510(k) pathway
Device trials
1
Naming "Ancora-SB"
MAUDE reports
0
Brand "Ancora-SB", since 2015
PubMed studies
0
Mentioning "Ancora-SB"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing Ancora-SB
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 2 of 2 decisions filed under this name.
- Ancora-SB510(k)
K260314 · Decided May 1, 2026 · 91 days after receipt
Device type: Enteroscope And Accessories (FDA) · GI, Urology & Nephrology
- Ancora-SB510(k)
K231323 · Decided Aug 31, 2023 · 115 days after receipt
Device type: Enteroscope And Accessories (FDA) · GI, Urology & Nephrology
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
No Medicare coverage document has a title matching this device or device type. Many devices are paid under existing codes without one.
Clinical trials
Device studies on ClinicalTrials.gov that name "Ancora-SB", any status and sponsor, newest update first.
- Ancora-SB Overtube Complete Positioning and Optical Visualization During Endoscopic ProceduresPivotal-lookingStatus unknown
Aspero Medical, Inc.Not on our public-company list
NCT06111131 · 123 participants (planned) · Start Jan 15, 2024 · Primary completion Mar 15, 2025
Device: Enteroscopy · For: Small Bowel Disease
Sites: Los Angeles, California; Baltimore, Maryland; St Louis, Missouri · 5 sites in all
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Ancora-SB", and for the whole product code for context.
This brand
0 reports: 0 malfunction, 0 injury, 0 death
Whole product code FDA
854 reports: 515 malfunction, 328 injury, 9 death
Newest reports for this brand
No MAUDE reports name this brand.
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "Ancora-SB"[tiab]. The summary above synthesizes these.
No PubMed record mentions this device by name.
Other devices of this type
Also filed under product code FDA.
- FUJIFILM Double Balloon Endoscope EI580BTFujifilm Corporation · 510(k) 2019
- FUJIFILM Stiffening Wire Device (SW-2000)FUJIFILM Healthcare Americas Corporation · 510(k) 2025
- Double Balloon Endoscope EN-840T, Over-tube TS-1214CFUJIFILM Healthcare Americas Corporation · 510(k) 2024
- Endoscope Model EN-580T, Over-tube TS-1314B, Balloon BS-4, Tube Kit TY-500DFujifilm Corporaton · 510(k) 2023
- Balloon BS-3Fujifilm Corporation · 510(k) 2021
- Arc EnterocuffBoddingtons Plastics, Ltd. · 510(k) 2020
- Fujifilm Double Balloon Endoscopes Models EN-530T and EN-580TFujifilm Medical Systems U.S.A, Inc. · 510(k) 2015
- Small Intestinal Videoscope SystemOlympus Medical Systems Corporation · 510(k) 2008
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.